2Schubert GA,Schilling L,Thomé C.Clazosentan,an endothelin receptor antagonist,prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage:a laser Doppler flowmetry study in rats[J].J Neurosurg,2008,109(6):1134.
3Jung CS,Iuliano BA,Harvey-White J,et al.Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine,an endogenous inhibitor of endothelial nitric oxide synthase,and cerebral vasospasm in a primate model of subarachnoid hemorrhage[J].J Neurosurg,2004,101(5):836.
4Harrod CG,Bendok BR,Batjer HH.Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage:a review[J].Neurosurgery,2005,56(4):633.
5Fountas KN,Tasiou A,Kapsalaki EZ,et al.Serum and cerebrospinal fluid c-reactive protein levels as predictors of vasospasm in aneurysmal subaraehnoid hemorrhage clinical article[J].Neurosurg Focus,2009,26(5):22.
6Lu H,Shi JX,Chen HL,et al.Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage[J].Brain Res,2009,1262:73.
